chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Insomnia, Lymphadenopathy, Pain in extremity, Pyrexia
Clinical narrative: Fever 101-103; chills; sweating; major joint pain; headache; sore arm; swelling of lymph nodes in neck and shoulder; inability to sleep; leg pain; bone pain; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27May2021 at 08:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and sulfonamide allergy. Concomitant medications included paroxetine hydrochloride (PAXIL) from an unknown date for an unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 2021 at 08:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient previously took aspirin (MANAFACTURER UNKNOWN) from an unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27May2021 at 14:30, the patient experienced fever 101-103, chills, sweating, major joint pain, headache, sore arm, swelling of lymph nodes in neck and shoulder, inability to sleep, leg pain, bone pain. All in a 28 hours period. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. On 27May2021, the patient underwent body temperature and the result was 101-103 (UNSPECIFIED UNITS). The clinical outcome of the events fever 101-103, chills, sweating, major joint pain, headache, sore arm, swelling of lymph nodes in neck and shoulder, inability to sleep, leg pain, bone pain was not recovered.  Information on the lot/batch number has been requested.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Loss of personal independence in daily activities, Migraine
Clinical narrative: Soreness on arm at injections site; Fatigue; Overall body and muscle soreness; Overall body and muscle stiffness; Shortness of breath; Chills; Fever; Severe headache; Migraine; Nausea; Difficulty eating and drinking due to nausea; Indegestion; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration on 08Apr2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included multivitamins on unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration on 17Mar2021 as a single dose for COVID-19 immunisation. On 08Apr2021, the patient experienced soreness on arm at injections site, fatigue, overall body muscle soreness and stiffness, shortness of breath, chills, fever, severe headache, migraine, nausea, indigestion, difficulty eating and drinking due to nausea. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events soreness on arm at injections site, fatigue, overall body muscle soreness and stiffness, shortness of breath, chills, fever, severe headache or migraine, nausea, indigestion, difficulty eating and drinking due to nausea were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Dyspepsia, Dysphagia, Dyspnoea, Fatigue
Clinical narrative: Soreness on arm at injections site; Fatigue; Overall body and muscle soreness; Overall body and muscle stiffness; Shortness of breath; Chills; Fever; Severe headache; Migraine; Nausea; Difficulty eating and drinking due to nausea; Indegestion; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration on 08Apr2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included multivitamins on unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration on 17Mar2021 as a single dose for COVID-19 immunisation. On 08Apr2021, the patient experienced soreness on arm at injections site, fatigue, overall body muscle soreness and stiffness, shortness of breath, chills, fever, severe headache, migraine, nausea, indigestion, difficulty eating and drinking due to nausea. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events soreness on arm at injections site, fatigue, overall body muscle soreness and stiffness, shortness of breath, chills, fever, severe headache or migraine, nausea, indigestion, difficulty eating and drinking due to nausea were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Migraine, Musculoskeletal stiffness, Myalgia, Nausea
Clinical narrative: Soreness on arm at injections site; Fatigue; Overall body and muscle soreness; Overall body and muscle stiffness; Shortness of breath; Chills; Fever; Severe headache; Migraine; Nausea; Difficulty eating and drinking due to nausea; Indegestion; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration on 08Apr2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included multivitamins on unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration on 17Mar2021 as a single dose for COVID-19 immunisation. On 08Apr2021, the patient experienced soreness on arm at injections site, fatigue, overall body muscle soreness and stiffness, shortness of breath, chills, fever, severe headache, migraine, nausea, indigestion, difficulty eating and drinking due to nausea. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events soreness on arm at injections site, fatigue, overall body muscle soreness and stiffness, shortness of breath, chills, fever, severe headache or migraine, nausea, indigestion, difficulty eating and drinking due to nausea were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Soreness on arm at injections site; Fatigue; Overall body and muscle soreness; Overall body and muscle stiffness; Shortness of breath; Chills; Fever; Severe headache; Migraine; Nausea; Difficulty eating and drinking due to nausea; Indegestion; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration on 08Apr2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included multivitamins on unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration on 17Mar2021 as a single dose for COVID-19 immunisation. On 08Apr2021, the patient experienced soreness on arm at injections site, fatigue, overall body muscle soreness and stiffness, shortness of breath, chills, fever, severe headache, migraine, nausea, indigestion, difficulty eating and drinking due to nausea. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events soreness on arm at injections site, fatigue, overall body muscle soreness and stiffness, shortness of breath, chills, fever, severe headache or migraine, nausea, indigestion, difficulty eating and drinking due to nausea were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Fatigue, Headache
Clinical narrative: Fever; Chills; Body aches; Dizziness; Diarrhea; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewo183) via an unspecified route of administration in the arm left on 26May2021 at 12:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Patient's medical history included hypertension, hypertrophic cardiomyopathy, COVID-19 and severe back problems. The patient's allergies included latex allergy, gabapentin (MANUFACTURER UNKNOWN) allergy, VALIUM allergy, PERCOCET allergy, LYRICA allergy, BENADRYL allergy. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included valsartan (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27May2021 the patient experienced fever, chills, body aches, dizziness, diarrhea and nausea. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. The patient did not receive any treatment for the adverse events. The clinical outcomes of the events fever, chills, body aches, dizziness, diarrhea and nausea were recovering at the time of reporting.   No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain
Clinical narrative: Fever; Chills; Body aches; Dizziness; Diarrhea; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewo183) via an unspecified route of administration in the arm left on 26May2021 at 12:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Patient's medical history included hypertension, hypertrophic cardiomyopathy, COVID-19 and severe back problems. The patient's allergies included latex allergy, gabapentin (MANUFACTURER UNKNOWN) allergy, VALIUM allergy, PERCOCET allergy, LYRICA allergy, BENADRYL allergy. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included valsartan (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27May2021 the patient experienced fever, chills, body aches, dizziness, diarrhea and nausea. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. The patient did not receive any treatment for the adverse events. The clinical outcomes of the events fever, chills, body aches, dizziness, diarrhea and nausea were recovering at the time of reporting.   No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Nausea, Pain
Clinical narrative: Fever; Chills; Body aches; Dizziness; Diarrhea; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewo183) via an unspecified route of administration in the arm left on 26May2021 at 12:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Patient's medical history included hypertension, hypertrophic cardiomyopathy, COVID-19 and severe back problems. The patient's allergies included latex allergy, gabapentin (MANUFACTURER UNKNOWN) allergy, VALIUM allergy, PERCOCET allergy, LYRICA allergy, BENADRYL allergy. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included valsartan (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27May2021 the patient experienced fever, chills, body aches, dizziness, diarrhea and nausea. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. The patient did not receive any treatment for the adverse events. The clinical outcomes of the events fever, chills, body aches, dizziness, diarrhea and nausea were recovering at the time of reporting.   No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; Chills; Body aches; Dizziness; Diarrhea; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewo183) via an unspecified route of administration in the arm left on 26May2021 at 12:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Patient's medical history included hypertension, hypertrophic cardiomyopathy, COVID-19 and severe back problems. The patient's allergies included latex allergy, gabapentin (MANUFACTURER UNKNOWN) allergy, VALIUM allergy, PERCOCET allergy, LYRICA allergy, BENADRYL allergy. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included valsartan (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27May2021 the patient experienced fever, chills, body aches, dizziness, diarrhea and nausea. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. The patient did not receive any treatment for the adverse events. The clinical outcomes of the events fever, chills, body aches, dizziness, diarrhea and nausea were recovering at the time of reporting.   No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Pain, Pyrexia
Clinical narrative: Fever; Chills; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewo183) via an unspecified route of administration in the right arm on 26May2021 at 12:00 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies. Concomitant medications were not reported. On 27May2021 the patient experienced fever, chills and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills and body aches were recovered with lasting effects on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Fever; Chills; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewo183) via an unspecified route of administration in the right arm on 26May2021 at 12:00 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies. Concomitant medications were not reported. On 27May2021 the patient experienced fever, chills and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills and body aches were recovered with lasting effects on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Blood pressure fluctuation, Chest pain, Computerised tomogram head normal, Dizziness
Clinical narrative: Felt generally unwell; extreme fatigue; headache; head pressure; high levels of anxiety; feelings of numbness and tingling in my face and base of skull; feelings of numbness and tingling in my face and base of skull; feelings of weakness in my left arm and left side of neck and chest; nausea; heart fluttering; heart palpitations; increased blood pressure; vertigo; ear pressure; pain in left ear; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 27Apr2021 (Lot Number: EW0164) at age of 42-year-old as dose 1, single for covid-19 immunisation. The patient is not pregnant at the time of the vaccination. Medical history included hashimoto's thyroiditis, iron-deficiency anemia. Concomitant medications within 2 weeks of vaccination included centrum multivitamin; levothyroxine sodium (SYNTHROID) at 125mg. The patient previously took penicillin and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient felt generally unwell day after vaccine on 28Apr2021 at 07:00 with extreme fatigue and headache. Side effects never went away. Worsening of condition and alarming new symptoms over the following two weeks (2021) prompted her to visit several doctors and the emergency room on one occasion. She experienced extreme headaches, head pressure, ear pressure/pain in left ear, high levels of anxiety, increased blood pressure, heart palpitations and fluttering, feelings of numbness and tingling in my face and base of skull, feelings of weakness in my left arm and left side of neck and chest, nausea and vertigo. No previous history of migraines, vertigo or high blood pressure. Bloodwork, urinalysis, CT scan and MRI of head showed no abnormalities. Months later, some symptoms have subsided, but she was on a twice daily dose of propranolol to control her blood pressure, anxiety and heart issues. She have been diagnosed with vertigo and have been receiving twice weekly vestibular therapy. Her health was still not where it was before this shot. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient was  undergoing vestibular rehab therapy at time of the report. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ear discomfort, Ear pain, Electrocardiogram normal, Fatigue, Full blood count normal
Clinical narrative: Felt generally unwell; extreme fatigue; headache; head pressure; high levels of anxiety; feelings of numbness and tingling in my face and base of skull; feelings of numbness and tingling in my face and base of skull; feelings of weakness in my left arm and left side of neck and chest; nausea; heart fluttering; heart palpitations; increased blood pressure; vertigo; ear pressure; pain in left ear; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 27Apr2021 (Lot Number: EW0164) at age of 42-year-old as dose 1, single for covid-19 immunisation. The patient is not pregnant at the time of the vaccination. Medical history included hashimoto's thyroiditis, iron-deficiency anemia. Concomitant medications within 2 weeks of vaccination included centrum multivitamin; levothyroxine sodium (SYNTHROID) at 125mg. The patient previously took penicillin and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient felt generally unwell day after vaccine on 28Apr2021 at 07:00 with extreme fatigue and headache. Side effects never went away. Worsening of condition and alarming new symptoms over the following two weeks (2021) prompted her to visit several doctors and the emergency room on one occasion. She experienced extreme headaches, head pressure, ear pressure/pain in left ear, high levels of anxiety, increased blood pressure, heart palpitations and fluttering, feelings of numbness and tingling in my face and base of skull, feelings of weakness in my left arm and left side of neck and chest, nausea and vertigo. No previous history of migraines, vertigo or high blood pressure. Bloodwork, urinalysis, CT scan and MRI of head showed no abnormalities. Months later, some symptoms have subsided, but she was on a twice daily dose of propranolol to control her blood pressure, anxiety and heart issues. She have been diagnosed with vertigo and have been receiving twice weekly vestibular therapy. Her health was still not where it was before this shot. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient was  undergoing vestibular rehab therapy at time of the report. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Head discomfort, Headache, Hypoaesthesia, Incomplete course of vaccination, Insomnia
Clinical narrative: Felt generally unwell; extreme fatigue; headache; head pressure; high levels of anxiety; feelings of numbness and tingling in my face and base of skull; feelings of numbness and tingling in my face and base of skull; feelings of weakness in my left arm and left side of neck and chest; nausea; heart fluttering; heart palpitations; increased blood pressure; vertigo; ear pressure; pain in left ear; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 27Apr2021 (Lot Number: EW0164) at age of 42-year-old as dose 1, single for covid-19 immunisation. The patient is not pregnant at the time of the vaccination. Medical history included hashimoto's thyroiditis, iron-deficiency anemia. Concomitant medications within 2 weeks of vaccination included centrum multivitamin; levothyroxine sodium (SYNTHROID) at 125mg. The patient previously took penicillin and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient felt generally unwell day after vaccine on 28Apr2021 at 07:00 with extreme fatigue and headache. Side effects never went away. Worsening of condition and alarming new symptoms over the following two weeks (2021) prompted her to visit several doctors and the emergency room on one occasion. She experienced extreme headaches, head pressure, ear pressure/pain in left ear, high levels of anxiety, increased blood pressure, heart palpitations and fluttering, feelings of numbness and tingling in my face and base of skull, feelings of weakness in my left arm and left side of neck and chest, nausea and vertigo. No previous history of migraines, vertigo or high blood pressure. Bloodwork, urinalysis, CT scan and MRI of head showed no abnormalities. Months later, some symptoms have subsided, but she was on a twice daily dose of propranolol to control her blood pressure, anxiety and heart issues. She have been diagnosed with vertigo and have been receiving twice weekly vestibular therapy. Her health was still not where it was before this shot. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient was  undergoing vestibular rehab therapy at time of the report. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging head normal, Metabolic function test normal, Middle ear effusion, Muscular weakness, Nausea
Clinical narrative: Felt generally unwell; extreme fatigue; headache; head pressure; high levels of anxiety; feelings of numbness and tingling in my face and base of skull; feelings of numbness and tingling in my face and base of skull; feelings of weakness in my left arm and left side of neck and chest; nausea; heart fluttering; heart palpitations; increased blood pressure; vertigo; ear pressure; pain in left ear; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 27Apr2021 (Lot Number: EW0164) at age of 42-year-old as dose 1, single for covid-19 immunisation. The patient is not pregnant at the time of the vaccination. Medical history included hashimoto's thyroiditis, iron-deficiency anemia. Concomitant medications within 2 weeks of vaccination included centrum multivitamin; levothyroxine sodium (SYNTHROID) at 125mg. The patient previously took penicillin and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient felt generally unwell day after vaccine on 28Apr2021 at 07:00 with extreme fatigue and headache. Side effects never went away. Worsening of condition and alarming new symptoms over the following two weeks (2021) prompted her to visit several doctors and the emergency room on one occasion. She experienced extreme headaches, head pressure, ear pressure/pain in left ear, high levels of anxiety, increased blood pressure, heart palpitations and fluttering, feelings of numbness and tingling in my face and base of skull, feelings of weakness in my left arm and left side of neck and chest, nausea and vertigo. No previous history of migraines, vertigo or high blood pressure. Bloodwork, urinalysis, CT scan and MRI of head showed no abnormalities. Months later, some symptoms have subsided, but she was on a twice daily dose of propranolol to control her blood pressure, anxiety and heart issues. She have been diagnosed with vertigo and have been receiving twice weekly vestibular therapy. Her health was still not where it was before this shot. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient was  undergoing vestibular rehab therapy at time of the report. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, Paraesthesia, Serum ferritin normal, Thyroid function test normal, Urine analysis normal
Clinical narrative: Felt generally unwell; extreme fatigue; headache; head pressure; high levels of anxiety; feelings of numbness and tingling in my face and base of skull; feelings of numbness and tingling in my face and base of skull; feelings of weakness in my left arm and left side of neck and chest; nausea; heart fluttering; heart palpitations; increased blood pressure; vertigo; ear pressure; pain in left ear; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 27Apr2021 (Lot Number: EW0164) at age of 42-year-old as dose 1, single for covid-19 immunisation. The patient is not pregnant at the time of the vaccination. Medical history included hashimoto's thyroiditis, iron-deficiency anemia. Concomitant medications within 2 weeks of vaccination included centrum multivitamin; levothyroxine sodium (SYNTHROID) at 125mg. The patient previously took penicillin and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient felt generally unwell day after vaccine on 28Apr2021 at 07:00 with extreme fatigue and headache. Side effects never went away. Worsening of condition and alarming new symptoms over the following two weeks (2021) prompted her to visit several doctors and the emergency room on one occasion. She experienced extreme headaches, head pressure, ear pressure/pain in left ear, high levels of anxiety, increased blood pressure, heart palpitations and fluttering, feelings of numbness and tingling in my face and base of skull, feelings of weakness in my left arm and left side of neck and chest, nausea and vertigo. No previous history of migraines, vertigo or high blood pressure. Bloodwork, urinalysis, CT scan and MRI of head showed no abnormalities. Months later, some symptoms have subsided, but she was on a twice daily dose of propranolol to control her blood pressure, anxiety and heart issues. She have been diagnosed with vertigo and have been receiving twice weekly vestibular therapy. Her health was still not where it was before this shot. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient was  undergoing vestibular rehab therapy at time of the report. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: Felt generally unwell; extreme fatigue; headache; head pressure; high levels of anxiety; feelings of numbness and tingling in my face and base of skull; feelings of numbness and tingling in my face and base of skull; feelings of weakness in my left arm and left side of neck and chest; nausea; heart fluttering; heart palpitations; increased blood pressure; vertigo; ear pressure; pain in left ear; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 27Apr2021 (Lot Number: EW0164) at age of 42-year-old as dose 1, single for covid-19 immunisation. The patient is not pregnant at the time of the vaccination. Medical history included hashimoto's thyroiditis, iron-deficiency anemia. Concomitant medications within 2 weeks of vaccination included centrum multivitamin; levothyroxine sodium (SYNTHROID) at 125mg. The patient previously took penicillin and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient felt generally unwell day after vaccine on 28Apr2021 at 07:00 with extreme fatigue and headache. Side effects never went away. Worsening of condition and alarming new symptoms over the following two weeks (2021) prompted her to visit several doctors and the emergency room on one occasion. She experienced extreme headaches, head pressure, ear pressure/pain in left ear, high levels of anxiety, increased blood pressure, heart palpitations and fluttering, feelings of numbness and tingling in my face and base of skull, feelings of weakness in my left arm and left side of neck and chest, nausea and vertigo. No previous history of migraines, vertigo or high blood pressure. Bloodwork, urinalysis, CT scan and MRI of head showed no abnormalities. Months later, some symptoms have subsided, but she was on a twice daily dose of propranolol to control her blood pressure, anxiety and heart issues. She have been diagnosed with vertigo and have been receiving twice weekly vestibular therapy. Her health was still not where it was before this shot. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient was  undergoing vestibular rehab therapy at time of the report. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Blood pressure increased, Blood pressure measurement, Blood test, Cardiac flutter
Clinical narrative: Felt generally unwell; extreme fatigue; headache; head pressure; high levels of anxiety; feelings of numbness and tingling in my face and base of skull; feelings of numbness and tingling in my face and base of skull; feelings of weakness in my left arm and left side of neck and chest; nausea; heart fluttering; heart palpitations; increased blood pressure; vertigo; ear pressure; pain in left ear; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 27Apr2021 (Lot Number: EW0164) at age of 42-year-old as dose 1, single for covid-19 immunisation. The patient is not pregnant at the time of the vaccination. Medical history included hashimoto's thyroiditis, iron-deficiency anemia. Concomitant medications within 2 weeks of vaccination included centrum multivitamin; levothyroxine sodium (SYNTHROID) at 125mg. The patient previously took penicillin and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient felt generally unwell day after vaccine on 28Apr2021 at 07:00 with extreme fatigue and headache. Side effects never went away. Worsening of condition and alarming new symptoms over the following two weeks (2021) prompted her to visit several doctors and the emergency room on one occasion. She experienced extreme headaches, head pressure, ear pressure/pain in left ear, high levels of anxiety, increased blood pressure, heart palpitations and fluttering, feelings of numbness and tingling in my face and base of skull, feelings of weakness in my left arm and left side of neck and chest, nausea and vertigo. No previous history of migraines, vertigo or high blood pressure. Bloodwork, urinalysis, CT scan and MRI of head showed no abnormalities. Months later, some symptoms have subsided, but she was on a twice daily dose of propranolol to control her blood pressure, anxiety and heart issues. She have been diagnosed with vertigo and have been receiving twice weekly vestibular therapy. Her health was still not where it was before this shot. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient was  undergoing vestibular rehab therapy at time of the report. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Ear discomfort, Ear pain, Fatigue, Head discomfort
Clinical narrative: Felt generally unwell; extreme fatigue; headache; head pressure; high levels of anxiety; feelings of numbness and tingling in my face and base of skull; feelings of numbness and tingling in my face and base of skull; feelings of weakness in my left arm and left side of neck and chest; nausea; heart fluttering; heart palpitations; increased blood pressure; vertigo; ear pressure; pain in left ear; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 27Apr2021 (Lot Number: EW0164) at age of 42-year-old as dose 1, single for covid-19 immunisation. The patient is not pregnant at the time of the vaccination. Medical history included hashimoto's thyroiditis, iron-deficiency anemia. Concomitant medications within 2 weeks of vaccination included centrum multivitamin; levothyroxine sodium (SYNTHROID) at 125mg. The patient previously took penicillin and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient felt generally unwell day after vaccine on 28Apr2021 at 07:00 with extreme fatigue and headache. Side effects never went away. Worsening of condition and alarming new symptoms over the following two weeks (2021) prompted her to visit several doctors and the emergency room on one occasion. She experienced extreme headaches, head pressure, ear pressure/pain in left ear, high levels of anxiety, increased blood pressure, heart palpitations and fluttering, feelings of numbness and tingling in my face and base of skull, feelings of weakness in my left arm and left side of neck and chest, nausea and vertigo. No previous history of migraines, vertigo or high blood pressure. Bloodwork, urinalysis, CT scan and MRI of head showed no abnormalities. Months later, some symptoms have subsided, but she was on a twice daily dose of propranolol to control her blood pressure, anxiety and heart issues. She have been diagnosed with vertigo and have been receiving twice weekly vestibular therapy. Her health was still not where it was before this shot. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient was  undergoing vestibular rehab therapy at time of the report. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypoaesthesia, Magnetic resonance imaging, Malaise, Muscular weakness
Clinical narrative: Felt generally unwell; extreme fatigue; headache; head pressure; high levels of anxiety; feelings of numbness and tingling in my face and base of skull; feelings of numbness and tingling in my face and base of skull; feelings of weakness in my left arm and left side of neck and chest; nausea; heart fluttering; heart palpitations; increased blood pressure; vertigo; ear pressure; pain in left ear; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 27Apr2021 (Lot Number: EW0164) at age of 42-year-old as dose 1, single for covid-19 immunisation. The patient is not pregnant at the time of the vaccination. Medical history included hashimoto's thyroiditis, iron-deficiency anemia. Concomitant medications within 2 weeks of vaccination included centrum multivitamin; levothyroxine sodium (SYNTHROID) at 125mg. The patient previously took penicillin and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient felt generally unwell day after vaccine on 28Apr2021 at 07:00 with extreme fatigue and headache. Side effects never went away. Worsening of condition and alarming new symptoms over the following two weeks (2021) prompted her to visit several doctors and the emergency room on one occasion. She experienced extreme headaches, head pressure, ear pressure/pain in left ear, high levels of anxiety, increased blood pressure, heart palpitations and fluttering, feelings of numbness and tingling in my face and base of skull, feelings of weakness in my left arm and left side of neck and chest, nausea and vertigo. No previous history of migraines, vertigo or high blood pressure. Bloodwork, urinalysis, CT scan and MRI of head showed no abnormalities. Months later, some symptoms have subsided, but she was on a twice daily dose of propranolol to control her blood pressure, anxiety and heart issues. She have been diagnosed with vertigo and have been receiving twice weekly vestibular therapy. Her health was still not where it was before this shot. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient was  undergoing vestibular rehab therapy at time of the report. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Palpitations, Paraesthesia, Urine analysis, Vertigo
Clinical narrative: Felt generally unwell; extreme fatigue; headache; head pressure; high levels of anxiety; feelings of numbness and tingling in my face and base of skull; feelings of numbness and tingling in my face and base of skull; feelings of weakness in my left arm and left side of neck and chest; nausea; heart fluttering; heart palpitations; increased blood pressure; vertigo; ear pressure; pain in left ear; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 27Apr2021 (Lot Number: EW0164) at age of 42-year-old as dose 1, single for covid-19 immunisation. The patient is not pregnant at the time of the vaccination. Medical history included hashimoto's thyroiditis, iron-deficiency anemia. Concomitant medications within 2 weeks of vaccination included centrum multivitamin; levothyroxine sodium (SYNTHROID) at 125mg. The patient previously took penicillin and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient felt generally unwell day after vaccine on 28Apr2021 at 07:00 with extreme fatigue and headache. Side effects never went away. Worsening of condition and alarming new symptoms over the following two weeks (2021) prompted her to visit several doctors and the emergency room on one occasion. She experienced extreme headaches, head pressure, ear pressure/pain in left ear, high levels of anxiety, increased blood pressure, heart palpitations and fluttering, feelings of numbness and tingling in my face and base of skull, feelings of weakness in my left arm and left side of neck and chest, nausea and vertigo. No previous history of migraines, vertigo or high blood pressure. Bloodwork, urinalysis, CT scan and MRI of head showed no abnormalities. Months later, some symptoms have subsided, but she was on a twice daily dose of propranolol to control her blood pressure, anxiety and heart issues. She have been diagnosed with vertigo and have been receiving twice weekly vestibular therapy. Her health was still not where it was before this shot. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient was  undergoing vestibular rehab therapy at time of the report. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angina pectoris, Anxiety, Blood test, Depression, Discomfort
Clinical narrative: Full body pins and needles; numb arm; malaise; chest pain; insomnia; cramped legs; brain fog/cannot feel the weight of my own body; cognitive dysfunction; This is a spontaneous report from a contactable consumer (patient). A 33-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 15May2021 (Lot Number: EW0186, expiration date not provide) at age of 33 years old as a single dose for covid-19 immunisation. The patient was not pregnancy at time of vaccination. The patient's medical history and concomitant medications were not reported. The patient experienced full body pins and needles, numb arm, malaise, chest pain, insomnia, cramped legs, brain fog/cannot feel the weight of my own body, cognitive dysfunction, all on 15May2021. The outcome of the events was not recovered. Clinical course: Full body pins and needles for a month, numb arm, malaise, cramped legs, chest pain, brain fog, cognitive dysfunction, insomnia. Currently the patient couldn't feel the weight of her own body for the last four weeks. These last two months had been hell. She couldn't convey how bad it was been. She felt lucky to be alive. All events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. No other vaccine received in four weeks. The patient was not COVID prior vaccination. The patient was not tested post vaccination.   Follow-up attempts are completed. No further information is expected.